MOTIV BTK Randomized Controlled Trial (NCT05406622)

🧪 Interventions in This Study

• MOTIV Sirolimus-Eluting Bioresorbable Scaffold (DEVICE)
• Percutaneous Transluminal Angioplasty (PTA) Device (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (26 Sites)

Showing the first 25 of 26 sites.

• California Heart and Vascular Clinic — El Centro, California
• Mission Cardiovascular Research Institute — Fremont, California
• Adventist Health — St. Helena, California
• Stanford University Medical Center — Stanford, California
• ClinRe — Thornton, Colorado
• Vascular Care Connecticut — Darien, Connecticut
• First Coast Cardiovascular Institute — Jacksonville, Florida
• Miami Cardiac & Vascular Institute — Miami, Florida
• Palm Vascular — Miami Beach, Florida
• Piedmont Atlanta Hospital — Atlanta, Georgia
• Pacific Vascular Institute — ‘Aiea, Hawaii
• Rush University Medical Center — Chicago, Illinois
• Advocate Christ Medical Center — Oak Lawn, Illinois
• UnityPoint Health Trinity Bettendorf Hospital — Bettendorf, Iowa
• Cardiovascular Medicine PC — Davenport, Iowa
• Cardiovascular Institute of the South — Houma, Louisiana
• The Vascular Care Group - Wellesley — Wellesley, Massachusetts
• Holy Name Medical Center — Teaneck, New Jersey
• Presbyterian Healthcare Services — Albuquerque, New Mexico
• Cleveland Clinic Foundation — Cleveland, Ohio
• Ballad Health System — Kingsport, Tennessee
• Texas Tech University — Lubbock, Texas
• North Dallas Research Associates — McKinney, Texas
• Baylor Research Institute — Plano, Texas
• Bellin Memorial Hospital — Green Bay, Wisconsin

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Critical Limb Ischemia

• Trial to Assess Chelation Therapy in Critical Limb Ischemia — Miami Beach, Florida
• Serrantor OCT Study — New York, New York
• FAZA PET/MRI in CLI Patients Pre and Post Revascularization — Toronto, Ontario
• PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia — La Jolla, California
• Nutrition in Patient With Critical Limb Ischemia — Boston, Massachusetts

Explore by condition: All Critical Limb Ischemia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.